Synonyms: ABR-215062 | TV-5600
Compound class:
Synthetic organic
Comment: Laquinimod is an experimental immunomodulator being investigated as an oral treatment for multiple sclerosis (MS) [2-5].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
5-chloro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide |
Synonyms ![]() |
ABR-215062 | TV-5600 |
Database Links ![]() |
|
CAS Registry No. | 248281-84-7 (source: SciFinder) |
ChEMBL Ligand | CHEMBL66092 |
DrugCentral Ligand | 4825 |
GtoPdb PubChem SID | 223365974 |
PubChem CID | 54677946 |
Search Google for chemical match using the InChIKey | GKWPCEFFIHSJOE-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | GKWPCEFFIHSJOE |
UniChem Compound Search for chemical match using the InChIKey | GKWPCEFFIHSJOE-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | GKWPCEFFIHSJOE-UHFFFAOYSA-N |
Wikipedia | Laquinimod |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Laquinimod (links to external site)
Cat. No. HY-13010 |